Avalon GloboCare Corp. (NASDAQ: ALBT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AVALON GLOBOCARE CORP.

Avalon GloboCare Corp. (NASDAQ: ALBT)
Listen to this Section


$0.37
+0.0160 ( +4.55% ) 90.8K

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Market Data


Open $0.37
Previous Close $0.35
Volume 90.8K
Market Cap $4.49M
Day Range $0.35 - $0.38
52 Week Range $0.21 - $4.74
Shares Outstanding 12.05M
Change % +4.55%
Net Change ▲ 0.0160
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2016
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
s-1 Registration statements 124 Apr 08, 2026
pre Proxies and info statements 17 Apr 02, 2026
8-k 8K-related 11 Apr 02, 2026
8-k 8K-related 11 Apr 01, 2026
10-k Annual reports 128 Mar 30, 2026
8-k 8K-related 11 Mar 30, 2026
8-k/a 8K-related 11 Mar 24, 2026
8-k 8K-related 12 Mar 10, 2026
schedule Other 2 Mar 05, 2026
def Proxies and info statements 17 Mar 02, 2026

Latest News


× Before browsing our site, please accept our cookies policy